125742 S1 M5 c4591001 A report cci mild liver

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

2

Document text

CCI_Mild liver
MedDRA Dictionary Version: 230
Status: ACTIVETerm Name: CCI_Mild liverCode: 90002941Extension: CCIReport Date/Time: 27-Oct-2020:10:50:21 AM EDT
Term Code Level Category Weight Scope
Venoocclusive liver disease 10047216 PT
Steatohepatitis 10076331 PT
Radiation hepatitis 10051015 PT
Portal fibrosis 10074726 PT
Peliosis hepatis 10034229 PT
Non-cirrhotic portal hypertension 10077259 PT
Non-alcoholic steatohepatitis 10053219 PT
Nonalcoholic fatty liver disease 10082249 PT
Lupus hepatitis 10067737 PT
Lupoid hepatic cirrhosis 10025129 PT
Liver transplant 10024714 PT
Liver sarcoidosis 10068664 PT
Liver disorder 10024670 PT
Ischaemic hepatitis 10023025 PT
Hepatitis toxic 10019795 PT
Hepatitis fulminant 10019772 PT
Hepatitis D 10019762 PT
Hepatitis chronic persistent 10019759 PT
Hepatitis chronic active 10019755 PT
Hepatitis B 10019731 PT
Hepatitis alcoholic 10019728 PT
Hepatitis acute 10019727 PT
Hepatic steatosis 10019708 PT
Hepatic steato-fibrosis 10077215 PT
Hepatic necrosis 10019692 PT
Hepatic infarction 10019680 PT
Hepatic fibrosis 10019668 PT
Hepatic displacement 10051565 PT
Congestive hepatopathy 10084058 PT
Hepatic cirrhosis 10019641 PT
Hepatic atrophy 10019637 PT
090177e196edd387\Final\Final On: 01-May-2021 00:13 (GMT)
FDA-CBER-2021-5683-0023961
Hepatic amyloidosis 10075251 PT
Granulomatous liver disease 10018704 PT
Fatty liver alcoholic 10016262 PT
Diabetic hepatopathy 10071265 PT
Cryptogenic cirrhosis 10063075 PT
Coma hepatic 10010075 PT
Cirrhosis alcoholic 10009208 PT
Chronic hepatitis C 10008912 PT
Chronic hepatitis B 10008910 PT
Chronic hepatitis 10008909 PT
Cholestasis 10008635 PT
Cholangitis sclerosing 10008609 PT
Cardiac cirrhosis 10054936 PT
Primary biliary cholangitis 10080429 PT
Biliary cirrhosis 10004659 PT
Autoimmune hepatitis 10003827 PT
Allergic hepatitis 10071198 PT
Alcoholic liver disease 10001627 PT
Acute yellow liver atrophy 10070815 PT
090177e196edd387\Final\Final On: 01-May-2021 00:13 (GMT)
FDA-CBER-2021-5683-0023962